Who Paid My Doc
Rachel Joyce
Nurse Practitioner, Psychiatric/Mental Health Santa Fe, NM Nurse Practitioner
NPI 1841956448 CMS profile 11271029
2504 Camino Entrada, Santa Fe, NM 87501
General payments
$12,500
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Rachel Joyce of Santa Fe, NM is reported in the CMS Open Payments database as having received $12,500 across 2 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
2 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $1,500 | 1 | |
| 2023 | General | $11,000 | 1 |
Beside peers
- Rachel Joyce
- Nurse Practitioner, Psychiatric/Mental Health median
- Middle half of Nurse Practitioner, Psychiatric/Mental Health
- National median
In program year 2025, general payments to Rachel Joyce were reported at $0. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.
Show as a table
| Year | Rachel Joyce | Nurse Practitioner, Psychiatric/Mental Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $0 | $166 | $54–$482 | $132 |
| 2022 | $0 | $195 | $66–$559 | $149 |
| 2023 | $11,000 | $233 | $82–$673 | $160 |
| 2024 | $1,500 | $236 | $84–$688 | $164 |
| 2025 | $0 | $258 | $93–$764 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 11 drugsPart D claims
264
Drug cost
$5,596
Branded share of claims
25.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | Brand | 42 | $4,065 | |
| Albuterol Sulfate Hfa Albuterol Sulfate | Brand | 11 | $384 | |
| Gabapentin | Generic | 54 | $371 | |
| Mirtazapine | Generic | 29 | $168 | |
| Hydroxyzine Hcl | Generic | 23 | $152 | |
| Prazosin Hcl | Generic | 15 | $99 | |
| Hydroxyzine Pamoate | Generic | 15 | $97 | |
| Ondansetron Odt Ondansetron | Brand | 14 | $89 | |
| Clonidine Hcl | Generic | 33 | $83 | |
| Methocarbamol | Generic | 14 | $58 |
The 10 drugs with the highest cost, of 11 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Records
2 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nurse Practitioner, Psychiatric/Mental Health in New Mexico
Ayanna Williams
Nurse Practitioner, Psychiatric/Mental Health · Roswell, NM
Martha Snow
Nurse Practitioner, Psychiatric/Mental Health · Albuquerque, NM
Vernon Osborn
Nurse Practitioner, Psychiatric/Mental Health · Gallup, NM
Jacqueline Tuton
Nurse Practitioner, Psychiatric/Mental Health · Las Cruces, NM
Jimmy Calzado
Nurse Practitioner, Psychiatric/Mental Health · Rio Rancho, NM
Mario Herrera
Nurse Practitioner, Psychiatric/Mental Health · Las Cruces, NM
Related records
Nurse Practitioner, Psychiatric/Mental Health in New Mexico
Practitioners in the same specialty and state, ranked by reported value.
All Nurse Practitioner, Psychiatric/Mental Health
Everyone recorded under this specialty, nationwide.
Doctors in New Mexico
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.